Galenika

Galenika is Serbia’s oldest pharmaceutical company with nearly eight decades of history. It manufactures over 250 products—primarily generic medicines but also dietary supplements and medical devices—serving Serbia as well as more than two dozen international markets across three continents. The company operates modern GMP-compliant facilities with significant annual production capacity for tablets/capsules/syrups/injectables/dental products. Since its acquisition by Brazil’s NC Group in late 2017 it has expanded into new EU markets through both organic growth and partnerships with global pharma companies such as Cantabria Labs and CromaPharma. Its product range covers most major therapeutic areas.